Ricker Pharmaceuticals Pvt Ltd - Due diligence report

A 360° intelligence report on Ricker Pharmaceuticals Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and …

1986-06-10 Kalyani, West Bengal Active Unlisted Active Compliant
Share
Connect MCP
RP Ricker Pharmaceuticals Pvt Ltd
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Ricker Pharmaceuticals Pvt Ltd — 360° Intelligence Report

Generated from MCA filings & public records
92/100
Trust Score
Low Risk

Ricker Pharmaceuticals Pvt Ltd is assessed as Low Risk with a Trust Score of 92/100. Ricker Pharmaceuticals Pvt Ltd is an active private limited indian non-government company incorporated in 1986, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 27 Jul 2026 from the latest processed filings. Ricker Pharmaceuticals Pvt Ltd snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
92/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (71.37 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
United Bank Of India1 48.0 cr
Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 3 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
JHUMA BOSE 01234567 Director 01/04/2018 6 yrs Approved
NARENDRA KUMAR BOSE 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 4 transfer(s)

Key managerial personnel: NARENDRA KUMAR BOSE (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 90
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Operating for 40+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence92/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment87/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 71.37 Lakh already registered.
  • Compliance record supports lending.
Investor view77/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 10 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
31 Mar 2016
Share transfer (FY 2016)
613.00000000 shares to BOSE RUMA
Share transfer (FY 2016)
33.00000000 shares to JHUMA
Share transfer (FY 2016)
556.00000000 shares to RANI MINU
Share transfer (FY 2016)
410.00000000 shares to JHUMA
10 May 2006
Charge created
United Bank Of India - 71.37 Lakh
22 May 1989
Director appointed
JHUMA BOSE (Director)
Director appointed
NARENDRA KUMAR BOSE (Managing Director)
10 Jun 1986
Incorporated
Registered with Roc Kolkata Ii
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Laxon Drugs Private Limited U51397CH1992PTC012679 Chandigarh, Chandigarh, India
Vivid Labs Private Limited U24230GJ1996PTC028977 Ahmedabad, Gujarat, India
Olivine Mercantiles Pvt Ltd U29692WB1984PTC038021 Kolkata, West Bengal, India
Jupiter Dyes Private Limited U24114MH1988PTC045879 Mumbai, Maharashtra, India
Shreenath Orgochem Private Limited U24110GJ1998PTC034080 Ahmedabad, Gujarat, India
A I C Chemicals Private Limited U24110MH1977PTC019619 Mumbai, Maharashtra, India
Lanark Laboratories Pvt Ltd U24232DL2001PTC111048 New Delhi, Delhi, India
The Oriental Chemical Works U24231WB1956PTC008003 Kolkata, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Ricker Pharmaceuticals Pvt Ltd before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Ricker Pharmaceuticals Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 60/100, margin trends, ownership structure and peer set for Ricker Pharmaceuticals Pvt Ltd - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 92/100, distress signals and MSME payment-delay disclosures - know whether Ricker Pharmaceuticals Pvt Ltd pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Ricker Pharmaceuticals Pvt Ltd - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Ricker Pharmaceuticals Pvt Ltd an active company?

Ricker Pharmaceuticals Pvt Ltd has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Ricker Pharmaceuticals Pvt Ltd financially healthy?

Ricker Pharmaceuticals Pvt Ltd has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Ricker Pharmaceuticals Pvt Ltd?

Its overall Trust Score is 92/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Ricker Pharmaceuticals Pvt Ltd?

See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

Does Ricker Pharmaceuticals Pvt Ltd have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Ricker Pharmaceuticals Pvt Ltd up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Ricker Pharmaceuticals Pvt Ltd?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.